endometrial cancer Clinical Trials and Research
Also known as: uterine cancer, cancer of the uterus lining, endometrial carcinoma, uterine corpus cancer, ec, adenocarcinoma of the endometrium · ICD-10: C54.1
Endometrial cancer is a type of cancer that starts in the lining of the uterus. Clinical trial research is focused on developing new therapies, improving early detection methods, and understanding disease progression. Find a Trial helps patients search for active studies exploring these advancements.
Search endometrial cancer trials →
Common questions about endometrial cancer clinical trials
What are the general eligibility requirements for endometrial cancer clinical trials?
Eligibility criteria vary by study but often include age, cancer stage, and overall health status. Patients typically need to meet specific medical criteria to ensure safety and study relevance. This information is detailed on ClinicalTrials.gov.
What are the different phases of clinical trials for endometrial cancer?
Clinical trials for endometrial cancer progress through phases (1, 2, 3, 4) to test safety, dosage, and effectiveness. Early phases focus on safety in small groups, while later phases compare new treatments to existing ones in larger populations, as outlined on ClinicalTrials.gov.
Do patients have to pay to participate in endometrial cancer clinical trials?
Costs covered by a clinical trial can vary. Often, the study sponsor covers research-related costs like experimental drugs or procedures. Routine medical care costs are typically billed to insurance. Patients should discuss financial details with the study team, as noted on ClinicalTrials.gov.
What new treatments are being investigated for endometrial cancer?
Researchers are exploring targeted therapies, immunotherapies, and novel chemotherapy combinations for endometrial cancer. Studies aim to find more effective treatments with fewer side effects, especially for advanced or recurrent disease. Data on these investigations can be found on ClinicalTrials.gov and NIH RePORTER.
What types of interventions are commonly studied in endometrial cancer trials?
Common interventions include new surgical techniques, radiation therapy protocols, and systemic treatments like chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Trials also investigate combinations of these approaches to improve patient outcomes, as seen on ClinicalTrials.gov.
Are there specific biomarkers important in endometrial cancer clinical trials?
Yes, biomarkers like microsatellite instability (MSI), PD-L1 expression, and specific genetic mutations (e.g., in POLE or p53) are increasingly important. These help identify patients who might respond best to certain targeted or immunotherapies, according to data on ClinicalTrials.gov and NIH RePORTER.
What are common reasons someone might be excluded from an endometrial cancer trial?
Common exclusion criteria can include other serious medical conditions, prior treatments that might interfere with the study drug, or certain types of previous cancers. Specific criteria ensure patient safety and the integrity of study results, as detailed on ClinicalTrials.gov.
What research is focused on recurrent or advanced endometrial cancer?
Many trials specifically target recurrent or advanced endometrial cancer, investigating new systemic therapies to control disease progression and improve quality of life. These studies often explore novel drug combinations or immunotherapies for patients with limited treatment options, as shown on ClinicalTrials.gov and NIH RePORTER.
How to find a endometrial cancer trial that fits you
- Describe your endometrial cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all endometrial cancer trials →